26.62
0.63 (2.40%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bullish | Bearish |
| Medical Devices (Global) | Bullish | Bearish | |
| Stock | Integra LifeSciences Holdings C | Bearish | Bearish |
Analyst Consensus
1 Buy, 3 Hold, 2 Sell
Avg. Price @ Call: 26.55
|
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| 52 Weeks Range |
22.36 - 50.78
|
|
| Price Target Range | ||
| High | 40.00 (JMP Securities, 50.29%) | Buy |
| Median | 25.50 (-4.19%) | |
| Low | 24.00 (Morgan Stanley, -9.83%) | Sell |
| Average | 29.67 (11.47%) | |
| Total | 1 Buy, 3 Hold, 2 Sell | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B of A Securities | 07 May 2024 | 26.00 (-2.31%) | Sell | 25.08 |
| JMP Securities | 07 May 2024 | 40.00 (50.29%) | Buy | 25.08 |
| 29 Feb 2024 | 49.00 (84.11%) | Buy | 36.91 | |
| Morgan Stanley | 07 May 2024 | 24.00 (-9.83%) | Sell | 25.08 |
| Truist Securities | 07 May 2024 | 25.00 (-6.07%) | Hold | 25.08 |
| 01 Mar 2024 | 41.00 (54.05%) | Hold | 35.99 | |
| Wells Fargo | 07 May 2024 | 25.00 (-6.07%) | Hold | 25.08 |
| Citigroup | 03 Apr 2024 | 38.00 (42.78%) | Hold | 33.90 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BRADLEY KEITH | 25.30 | 25.99 | 8,457 | 213,797 |
| CLAY SHAUNDRA | 25.30 | - | 8,696 | 220,009 |
| ESSIG STUART | 25.30 | - | 13,835 | 350,026 |
| GRAVES JEFFREY A | 25.30 | - | 10,278 | 260,033 |
| HILL BARBARA B | 25.30 | - | 11,859 | 300,033 |
| LO RENEE WONLAI | 25.30 | - | 8,696 | 220,009 |
| MURPHY RAYMOND G. | 25.30 | - | 8,696 | 220,009 |
| SCHADE CHRISTIAN S | 25.30 | - | 8,696 | 220,009 |
| Aggregate Net Quantity | 79,213 | |||
| Aggregate Net Value ($) | 2,003,924 | |||
| Aggregate Avg. Buy ($) | 25.30 | |||
| Aggregate Avg. Sell ($) | 25.99 | |||
| Insider Range ($) | ||||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BRADLEY KEITH | Director | 12 May 2024 | Disposed (-) | 239 | 25.99 | 6,212 |
| BRADLEY KEITH | Director | 09 May 2024 | Acquired (+) | 8,696 | 25.30 | 220,009 |
| SCHADE CHRISTIAN S | Director | 09 May 2024 | Acquired (+) | 8,696 | 25.30 | 220,009 |
| MURPHY RAYMOND G. | Director | 09 May 2024 | Acquired (+) | 8,696 | 25.30 | 220,009 |
| LO RENEE WONLAI | Director | 09 May 2024 | Acquired (+) | 8,696 | 25.30 | 220,009 |
| HILL BARBARA B | Director | 09 May 2024 | Acquired (+) | 11,859 | 25.30 | 300,033 |
| GRAVES JEFFREY A | Director | 09 May 2024 | Acquired (+) | 10,278 | 25.30 | 260,033 |
| CLAY SHAUNDRA | Director | 09 May 2024 | Acquired (+) | 8,696 | 25.30 | 220,009 |
| ESSIG STUART | Officer | 09 May 2024 | Acquired (+) | 13,835 | 25.30 | 350,026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |